(Q46662873)

24 December 2017

title

Effect of an oral contraceptive on emotional distress, anxiety and depression of women with polycystic ovary syndrome: a prospective study (English)

1 reference

24 December 2017

polycystic ovary syndrome

main subject

1 reference

1 reference

1 reference

ORCID Public Data File 2021

author name string

Nese Cinar

1

1 reference

24 December 2017

Ayla Harmanci

2

1 reference

24 December 2017

Basaran Demir

3

1 reference

24 December 2017

Bulent O Yildiz

4

1 reference

24 December 2017

language of work or name

English

0 references

publication date

3 April 2012

1 reference

24 December 2017

published in

Human Reproduction

1 reference

24 December 2017

volume

27

1 reference

24 December 2017

issue

6

1 reference

24 December 2017

page(s)

1840-1845

1 reference

24 December 2017

The prevalence and features of the polycystic ovary syndrome in an unselected population

cites work

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES113

Quality of life and psychological well being in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES113

An Inventory for Measuring Depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES113

Prevalence and implications of anxiety in polycystic ovary syndrome: results of an internet-based survey in Germany.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES113

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES113

Development of a health-related quality-of-life questionnaire (PCOSQ) for women with polycystic ovary syndrome (PCOS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES113

Anxiety and depression in polycystic ovary syndrome: a comprehensive investigation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES113

Increased risk for abnormal depression scores in women with polycystic ovary syndrome: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES113

Androgens in polycystic ovary syndrome: the role of exercise and diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES113

Psychiatric Illness in General Practice: A Detailed Study Using a New Method of Case Identification

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES113

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES113

Metformin treatment of polycystic ovary syndrome improves health-related quality-of-life, emotional distress and sexuality

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES113

International experiences with the Hospital Anxiety and Depression Scale--a review of validation data and clinical results

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES113

Impact of oral contraceptive pill use on premenstrual mood: predictors of improvement and deterioration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES113

Risk of depression and other mental health disorders in women with polycystic ovary syndrome: a longitudinal study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES113

Insulin sensitizing drugs for weight loss in women of reproductive age who are overweight or obese: systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES113

To what extent do oral contraceptives influence mood and affect?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES113

Structured exercise training programme versus hypocaloric hyperproteic diet in obese polycystic ovary syndrome patients with anovulatory infertility: a 24-week pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES113

Six weeks of structured exercise training and hypocaloric diet increases the probability of ovulation after clomiphene citrate in overweight and obese patients with polycystic ovary syndrome: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES113

Depression in women with polycystic ovary syndrome: clinical and biochemical correlates

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES113

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES113

Lifestyle management improves quality of life and depression in overweight and obese women with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES113

Androgens and mood dysfunction in women: comparison of women with polycystic ovarian syndrome to healthy controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES113

Increased circulating soluble P-selectin in polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES113

21 January 2018

Identifiers

DOI

10.1093/HUMREP/DES113

1 reference

24 December 2017

release_6obzaja2w5ffthmnnec5mfnrny

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/6obzaja2w5ffthmnnec5mfnrny

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

22473394

1 reference

24 December 2017